Dr. Xin He's research lab focuses on understanding how genetic variations affect RNA modifications in immune cells, which may contribute to human diseases. Their work specifically looks at a type of RNA modification called N6-methyladenosine (m6A), which plays a crucial role in regulating RNA processing. By investigating these genetic variants, the lab aims to identify potential therapeutic targets for immune-related disorders.

Dr. Chuan He's research lab at the University of Chicago focuses on understanding DNA modifications, particularly epigenetic changes that affect gene expression. They are developing new methods to label and sequence specific chemical changes in DNA, particularly 5-hydroxymethylcytosine and 5-methylcytosine, which may have significant implications for diagnosing and treating diseases. This research is crucial for both basic science and clinical applications, promising advancements in how we study and understand genetics and health.

Dr. Joel Voss's lab at the University of Chicago focuses on understanding how the human hippocampus contributes to forming and retrieving memories. By studying individuals with epilepsy and using advanced brain recording techniques, the lab investigates the brain's mechanisms during memory formation processes, especially regarding how memory is influenced by visual sampling. Their work aims to uncover insights that could lead to new treatments for memory-related disorders.

Jun Huang's lab at the University of Chicago focuses on developing innovative treatments for Alzheimer's Disease (AD) using advanced biotechnology. The lab is exploring how to engineer microglia, the brain's immune cells, to more effectively clear harmful amyloid-beta plaques associated with AD. Their work aims to create microglia that can recognize and degrade these plaques to help slow the disease's progression.

Dr. Sarah Cobey's lab at the University of Chicago focuses on understanding immune responses to influenza vaccination. They use computational models to explore how individual differences affect vaccine effectiveness, and the lab aims to improve vaccine design based on these insights. By analyzing immune responses over time, they seek to identify factors that contribute to better protection against influenza infection.

Dr. Benoit Roux's research lab at the University of Chicago focuses on using molecular dynamics simulations to investigate how potassium (Kv) and sodium (Nav) channels function within biological membranes. The lab aims to understand the complex interactions that influence ion channel behavior, particularly in relation to neurological disorders and cardiac functions. By improving computational models, the lab seeks to explore the fundamental forces that guide ion permeation and channel activation, which are critical for human health.

The lab led by Dr. Narayanan Kasthuri at the University of Chicago focuses on advancing microscopy techniques to better understand brain connectivity. Their innovative research involves developing a new type of electron microscope that utilizes photonic technology to enable high-resolution imaging of the brain's neural connections. This technology aims to make connectomics more accessible and efficient, paving the way for detailed studies of brain structure in various organisms.

Dr. Barbara Kee's lab studies natural killer (NK) cells, which are crucial for our body’s defense against viral infections and cancer. The group focuses on understanding the role of a specific protein called BATF in regulating NK cell behavior during infections and tumor responses. By exploring how NK cells can be enhanced or altered, the lab aims to develop potential therapies that can leverage NK cells to better fight diseases like tumors and viral infections.

Dr. Robert J Keenan's lab at the University of Chicago focuses on understanding how membrane proteins are created and folded in cells. These proteins play essential roles in various cellular functions and their improper folding can lead to diseases. The lab's research investigates the molecular mechanisms behind the assembly of multi-pass membrane proteins, crucial for both cell functionality and health. By studying these processes, they aim to provide insights that may help address various human diseases related to membrane protein dysfunction.

Dr. Matthew Tirrell's lab at the University of Chicago focuses on using targeted nanomedicine to address serious lung diseases like acute respiratory distress syndrome (ARDS) and pulmonary fibrosis. Their innovative approach seeks to modify specific cell types during different phases of lung disease, particularly in response to viral infections such as COVID-19. The lab aims to develop new therapies that can effectively reduce lung injury and fibrosis, offering hope for improved treatment options in the future.

Dr. Margaret Lise Gardel's research lab focuses on how cells interact with mechanical signals to influence their behavior, such as growth and movement. Through a combination of techniques, including live imaging and mathematical modeling, the lab investigates how the structures within cells, particularly the cytoskeleton, respond to forces. This work is significant for understanding not only basic biology but also potential treatments for diseases like cancer and heart conditions.

The lab of Dr. Raymond E. Moellering at the University of Chicago focuses on developing innovative strategies to combat triple-negative breast cancer (TNBC) by targeting specific transcription factors that drive tumor growth. Using engineered synthetic transcriptional repressors (STRs), the lab aims to inhibit the activity of key proteins that enable cancer cells to survive in stressful environments. This research not only seeks to advance our understanding of cancer biology but also to create novel therapeutic options that could improve patient outcomes.

Dr. Carole Ober's lab at the University of Chicago focuses on understanding asthma and allergic diseases, which affect many people around the world. The lab aims to identify genetic factors that contribute to these diseases and to explore how they impact different types of immune cells in the body. By doing this research, they hope to uncover new drug targets that can lead to better treatments for patients.

Dr. Tao Pan's lab at the University of Chicago focuses on understanding small nucleolar RNAs (snoRNAs), which are important molecules that help guide modifications in ribosomal RNA and can influence gene expression. By using advanced sequencing technologies, the lab aims to uncover the roles and interactions of these snoRNAs in human cells and how they impact various biological processes and diseases. This work could provide new insights into genome regulation and RNA-based therapies.

Dr. Joseph Piccirilli's lab at the University of Chicago focuses on understanding the role and structure of non-coding RNAs and their complexes with proteins and small molecules. They utilize innovative chemical and biochemical methods to investigate how these RNAs function in health and disease. By developing synthetic antibodies and studying catalytic RNAs, the lab aims to reveal critical insights into RNA structures and their biological significance.

Dr. Wei Wei's lab at the University of Chicago focuses on understanding how neurons in the retina, specifically starburst amacrine cells, process visual motion signals. By examining the dynamic interactions between a neuron’s physical structure and its input from other neurons, the lab aims to uncover principles of how motion detection happens at a cellular level. This research has implications for understanding normal vision and could help in treating visual disorders.

The lab of Callum F. Ross at the University of Chicago investigates how the brain controls the movements of the tongue, which is crucial for eating and speaking. They study the biomechanics of tongue movement by analyzing muscle and brain activity during various feeding behaviors. This research aims to improve rehabilitation methods for individuals who have lost normal tongue function due to diseases or surgeries.

Dr. Mark Sheffield's research lab focuses on understanding the brain mechanisms behind fear memories, particularly in the context of post-traumatic stress disorder (PTSD). His team investigates how specific brain regions communicate to suppress fearful memories and aid in the extinction process, helping to provide insights that could lead to better treatments for PTSD. Utilizing advanced techniques like virtual reality and two-photon microscopy, they explore the interactions between the thalamus and hippocampus, key areas involved in memory processing.

Dr. Tobin R Sosnick's lab at the University of Chicago focuses on understanding how proteins, especially membrane and disordered proteins, work and fold. They use advanced techniques to study how these proteins transport molecules across cell membranes and how they behave under stress. This research is not only foundational for biology but also has practical implications for drug development and understanding disease processes.

Dr. Shyam Prabhakaran's research focuses on improving the emergency evaluation and transfer processes for stroke patients. His lab conducts studies that aim to enhance the Door-In-Door-Out (DIDO) protocol to ensure patients get timely access to comprehensive stroke care. Through interdisciplinary collaboration, the lab seeks to develop and implement effective strategies that can reduce delays in treatment and improve outcomes for stroke patients nationwide.